Krystal Biotech, Inc.

PITTSBURGH, PA · Founded 2017 · CIK 0001711279 · Biotech · Public

HSV-1 based gene delivery platform for treating genetic diseases

krystalbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$11M
1 Form D · Aug 2017
110 months since last filing
Contracts
—
No federal contracts on record
Patents
40
17 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,254,534
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1882IMMUNO NANO MED, INC——
1883MycoRx LLC—$600K
1884Biosplice Therapeutics——
1885Krystal Biotech, Inc.—$11M
1886SANOSTEM GLOBAL, LLC—$3.5M
1887Protocol 46 Inc.—$410K
1888RETROVIROX, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Dan JanneyDirector
  • Krish KrishnanDirector · Executive Officer
  • Suma KrishnanDirector
  • Doug NorbyDirector
  • Dino RossiDirector

Patents

USPTO · 17 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.